The World Health Organization has released its long-anticipated recommendation on cannabis scheduling. But rather than removing it from Schedule I of the Single Convention, it only removes it from Schedule IV, where it is also listed. CBD has been descheduled altogether. The “critical review” from the WHO’s Expert Committee on Drug Dependence, promised last year, is […]

U.S. regulators are studying whether restrictions on marijuana should be eased, a step toward decriminalizing the drug at the federal level. The Food and Drug Administration is conducting an analysis at the Drug Enforcement Administration’s request on whether the U.S. should downgrade the classification of marijuana as a Schedule 1 drug, said Douglas Throckmorton, Deputy […]

“The DEA: Four Decades of Impeding and Rejecting Science,” released by the Multidisciplinary Association for Psychedelic Studies (MAPS) and DPA, calls on the Drug Enforcement Administration (DEA) to end its “unjustifiable” monopoly of the supply of research grade marijuana available for federally approved research. According to the report, the DEA has maintained marijuana’s classification as a […]